Related Experiment Videos
Solubility engineering and crystallization of human apolipoprotein D.
Amber Nasreen1, Martin Vogt, Hyun Jin Kim
1Lehrstuhl für Biologische Chemie, Technische Universität München, D-85350 Freising-Weihenstephan, Germany.
Protein Science : a Publication of the Protein Society
|December 3, 2005
Summary
Researchers engineered a human apolipoprotein D (ApoD) mutant to improve protein stability and yield. This enhanced ApoD facilitates structural studies, offering new insights into its biological functions.
Area of Science:
- Biochemistry
- Structural Biology
- Protein Engineering
Background:
- Human apolipoprotein D (ApoD) is a lipocalin family member found in HDL, body fluids, and neuronal tissue.
- Recombinant ApoD exhibits ligand-binding but suffers from aggregation, hindering structural analysis.
Purpose of the Study:
- To systematically engineer a more stable and soluble form of human apolipoprotein D.
- To facilitate future structural investigations of ApoD.
Main Methods:
- Site-directed mutagenesis targeting exposed hydrophobic residues in recombinant ApoD.
- Perplasmic biosynthesis in Escherichia coli.
- Gel permeation chromatography for assessing protein homogeneity.
- Crystallization for X-ray structural analysis.
Main Results:
- A triple mutant (W99H, I118S, L120S) showed improved yield and monomeric elution.
- The mutant retained physiological ligand-binding activity.
- The engineered ApoD was successfully crystallized, indicating conformational homogeneity.
Conclusions:
- The developed ApoD mutant overcomes previous stability issues.
- This engineered protein is suitable for X-ray structural analysis.
- Provides a foundation for understanding ApoD's biological roles.